Literature DB >> 23389286

Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy.

Susana Gonçalves1, Tiago Fleming Outeiro.   

Abstract

Alpha-synuclein (aSyn) is implicated in Parkinson's disease and several other neurodegenerative disorders. To date, the function and intracellular dynamics of aSyn are still unclear. Here, we tracked the dynamics of aSyn using photoactivatable green fluorescent protein as a reporter. We found that the availability of the aSyn N terminus modulates its shuttling into the nucleus. Interestingly, familial aSyn mutations altered the dynamics at which the protein distributes throughout the cell. Both the A30P and A53T aSyn mutations increase the speed at which the protein moves between the nucleus and cytoplasm, respectively. We also found that specific kinases potentiate the shuttling of aSyn between nucleus and cytoplasm. A mutant aSyn form that blocks S129 phosphorylation, S129A, results in the formation of cytoplasmic inclusions, suggesting phosphorylation modulates aggregation in addition to modulating aSyn intracellular dynamics. Finally, we found that the molecular chaperone HSP70 accelerates the entry of aSyn into the nuclear compartment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23389286      PMCID: PMC3637893          DOI: 10.1007/s12035-013-8406-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  53 in total

1.  A photoactivatable GFP for selective photolabeling of proteins and cells.

Authors:  George H Patterson; Jennifer Lippincott-Schwartz
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

2.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.

Authors:  P H Weinreb; W Zhen; A W Poon; K A Conway; P T Lansbury
Journal:  Biochemistry       Date:  1996-10-29       Impact factor: 3.162

3.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein.

Authors:  M Okochi; J Walter; A Koyama; S Nakajo; M Baba; T Iwatsubo; L Meijer; P J Kahle; C Haass
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

5.  Synucleins are a novel class of substrates for G protein-coupled receptor kinases.

Authors:  A N Pronin; A J Morris; A Surguchov; J L Benovic
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

6.  Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease.

Authors:  Jennifer C Lee; Ralf Langen; Patrick A Hummel; Harry B Gray; Jay R Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-09       Impact factor: 11.205

7.  The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast.

Authors:  Katherina Vamvaca; Michael J Volles; Peter T Lansbury
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

8.  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Authors:  Juan J Zarranz; Javier Alegre; Juan C Gómez-Esteban; Elena Lezcano; Raquel Ros; Israel Ampuero; Lídice Vidal; Janet Hoenicka; Olga Rodriguez; Begoña Atarés; Verónica Llorens; Estrella Gomez Tortosa; Teodoro del Ser; David G Muñoz; Justo G de Yebenes
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

9.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

10.  Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system.

Authors:  Kelly J Inglis; David Chereau; Elizabeth F Brigham; San-San Chiou; Susanne Schöbel; Normand L Frigon; Mei Yu; Russell J Caccavello; Seth Nelson; Ruth Motter; Sarah Wright; David Chian; Pamela Santiago; Ferdie Soriano; Carla Ramos; Kyle Powell; Jason M Goldstein; Michael Babcock; Ted Yednock; Frederique Bard; Guriqbal S Basi; Hing Sham; Tamie J Chilcote; Lisa McConlogue; Irene Griswold-Prenner; John P Anderson
Journal:  J Biol Chem       Date:  2008-11-12       Impact factor: 5.157

View more
  28 in total

1.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

Review 2.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

3.  Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.

Authors:  Filsy Samuel; William P Flavin; Sobia Iqbal; Consiglia Pacelli; Sri Dushyaanthan Sri Renganathan; Louis-Eric Trudeau; Edward M Campbell; Paul E Fraser; Anurag Tandon
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

4.  The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson's disease SNCA mutations.

Authors:  Vivian Chen; Malik Moncalvo; Dominic Tringali; Lidia Tagliafierro; Ahila Shriskanda; Ekaterina Ilich; Wendy Dong; Boris Kantor; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

5.  The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

Authors:  Mohamed-Bilal Fares; Nadine Ait-Bouziad; Igor Dikiy; Martial K Mbefo; Ana Jovičić; Aoife Kiely; Janice L Holton; Seung-Jae Lee; Aaron D Gitler; David Eliezer; Hilal A Lashuel
Journal:  Hum Mol Genet       Date:  2014-04-11       Impact factor: 6.150

6.  Phosphorylation Interferes with Maturation of Amyloid-β Fibrillar Structure in the N Terminus.

Authors:  Nasrollah Rezaei-Ghaleh; Sathish Kumar; Jochen Walter; Markus Zweckstetter
Journal:  J Biol Chem       Date:  2016-06-01       Impact factor: 5.157

7.  Multiplication of the SNCA locus exacerbates neuronal nuclear aging.

Authors:  Lidia Tagliafierro; Madison Elena Zamora; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

Review 8.  A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: Emerging concepts and challenges.

Authors:  Velmarini Vasquez; Joy Mitra; Haibo Wang; Pavana M Hegde; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2019-12-18       Impact factor: 11.685

9.  TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease.

Authors:  Andreas Bender; Paula Desplats; Brian Spencer; Edward Rockenstein; Anthony Adame; Matthias Elstner; Christoph Laub; Sarina Mueller; Andrew O Koob; Michael Mante; Emily Pham; Thomas Klopstock; Eliezer Masliah
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 10.  Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.

Authors:  Nelson de Oliveira Manzanza; Lucia Sedlackova; Raj N Kalaria
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.